skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis

Case report

(2975) Views  (900) Full article downloads

Authors: Dimitrios Karagiannis, Ilias Georgalas, Ioannis Ladas, Parikakis Eustratios, Panagiotis Mitropoulos

Published Date December 2008 Volume 2009:4 Pages 63 - 65
DOI: http://dx.doi.org/10.2147/CIA.S4803

Dimitrios Karagiannis1, Ilias Georgalas2, Ioannis Ladas2, Parikakis Eustratios1, Panagiotis Mitropoulos1

1Second Department of Ophthalmiatrion Eye Hospital, NHS, Athens, Greece; 2Department of Ophthalmology, “G.Genimatas” General Hospital, Athens, Greece

Abstract: A 65-year-old lady presented with decreased vision in her left eye (LE). Best corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic juxtafoveal retinal telangiectasis associated with subretinal neovascularization and she was treated with intravitreal ranibizumab every month for three months in the LE. After four months, her BCVA increased to 3/10. Fluorescein angiography (FA) showed minimal leakage and optical coherence tomography (OCT) confirmed absence of intra- or subretinal fluid in the macula. Examinations were repeated monthly for another 12 months and showed no recurrence. Intravitreal ranibizumab showed promising results for subretinal neovascularization due to idiopathic juxtafoveal retinal telangiectasis. A prospective study with large series of patients and controls may be necessary in order to determine the effectiveness of this treatment.

Keywords: idiopathic juxtafoveal retinal telangiectasis, ranibizumab, subretinal neovascularization






 

Other articles by Dr Ilias Georgalas

Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma
Angioid streaks, clinical course, complications, and current therapeutic management
Contemporary aspects in the prognosis of traumatic hyphemas
Cytomegalovirus retinitis presenting as vasculitis in a patient with Wegener’s granulomatosis
Foveal thickness after phacoemulsification as measured by optical coherence tomography
Lens-induced glaucoma in the elderly
Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy
Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
Preliminary results following the use of a fixed combination of timolol–brimonidine in patients with ocular hypertension and primary open-angle glaucoma
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab


Readers of this article also read:

Angioid streaks, clinical course, complications, and current therapeutic management
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Research methodological issues in evaluating herbal interventions
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine
Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy
Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia
Erratum